A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
12/1999
12/09/1999	CA2334809A1 Texaphyrin conjugates and uses thereof
12/09/1999	CA2333994A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
12/09/1999	CA2333988A1 Matthiola seed oil, mixtures containing it and use thereof
12/09/1999	CA2333975A1 Method of inhibiting angiogenesis and tumor growth and preventing tumor growth and metastases
12/09/1999	CA2331370A1 Protein oligomer compositions comprising endostatin protein and methods of using the same
12/09/1999	CA2330833A1 Human minor vault protein p193
12/09/1999	CA2330227A1 Method for triggering apoptosis in cells
12/09/1999	CA2330027A1 Method for preparation and in vivo administration of antigen presenting cell composition
12/09/1999	CA2329940A1 Use of genetically engineered antibodies to cd38 to treat multiple myeloma
12/09/1999	CA2328291A1 Substituted indolinones, the preparation thereof and their use as pharmaceutical compositions
12/09/1999	CA2299389A1 Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors
12/08/1999	EP0962467A1 Antibody against human parathormone related peptides
12/08/1999	EP0962463A1 Uncharged morpholino-based polymers having phosphorus-containing chiral intersubunit linkages
12/08/1999	EP0961833A1 Human plasma hyaluronidase
12/08/1999	EP0961831A1 Human endokine alpha
12/08/1999	EP0961780A1 Protein markers for lung cancer and use thereof
12/08/1999	EP0961779A1 SUBSTITUTED AMINO BICYCLIC-$g(b)-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS
12/08/1999	EP0961775A2 Purine l-nucleosides, analogs and uses thereof
12/08/1999	EP0961772A1 2,4-diaminopyrimidine compounds as anti-cancer agents
12/08/1999	EP0961612A1 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
12/08/1999	EP0775158B1 Cyclopeptolides
12/08/1999	EP0678086B1 Compounds having selectivity for retinoid x receptors
12/08/1999	EP0522078B1 Gp75 as a tumor vaccine for melanoma
12/08/1999	CN1237980A Polypptides comprising GAX protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acid and their use
12/08/1999	CN1237979A Conformationally constrained LH-RH analogues, their ues and pharmaceutical composisions containing them
12/08/1999	CN1237974A Process for producing ecteinascidin compounds
12/08/1999	CN1237970A Epothilone C. D. E and F, production process, and their use as cytostatic as well as phytosanitary agents
12/08/1999	CN1237955A Substituted phenols and thiophenols useful as antioxidant agents
12/08/1999	CN1237909A Cancer immunotherapy using tumor cells combined with mixed lymphocytes
12/08/1999	CN1237901A Protein stabilized pharmacologically active agents, methods for preparation thereof and methods for use thereof
12/08/1999	CN1237580A Phosphononooxymethyl ethers of taxame derivatives
12/08/1999	CN1237429A Medicine for curing tumor and its preparation method
12/08/1999	CN1237423A Auxiliary medicine for curing tumor, its preparation method and application
12/08/1999	CN1237414A Microcapsule containing chemotherapeutic medicine and capsule-forming method
12/07/1999	US5998648 Anticancer (IV) complexes for oral administration and a method of making the same
12/07/1999	US5998600 β-catenin, TCF-4, and APC interact to prevent cancer
12/07/1999	US5998597 The treatment of a particular volume of plant or animal tissue comprising the steps of treating the plant or animal tissue with at least one photo-active molecular agent.
12/07/1999	US5998583 BH3 interacting domain death agonist
12/07/1999	US5998579 Epimorphin antagonist and process for producing it
12/07/1999	US5998481 Fluoroalkyl/alkenyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
12/07/1999	US5998447 Heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
12/07/1999	US5998443 Phosphorous containing benzothiophenes for treating estrogen deficiency
12/07/1999	US5998442 Benzo [B] thiophene compounds, and compositions for treating bone loss, and hyperlipidemia
12/07/1999	US5998426 9,10 disubstituted camptothecin derivatives with antitumor activity
12/07/1999	US5998402 Osteoporosis; cardiovascular disorders; anticancer agents;postmemopause therapy
12/07/1999	US5998401 Naphthyl compounds, intermediates, compositions, and methods
12/07/1999	US5998395 Methods of treating inflammatory dermatosis
12/07/1999	US5998390 Combination of bisphosphonate and tetracycline
12/07/1999	US5998384 Endoscopic administration of an HSV-tk gene to treat digestive organ cancer
12/07/1999	US5998383 Antitumor antisense sequences directed against ribonucleotide reductase
12/07/1999	US5998377 Administration of lh-rh antagonist cetrorelix in combination with at least one .alpha.-reductase inhibitor; without the side effects associated with testosterone levels being in a castration range.
12/07/1999	US5998362 Conjugates useful in the treatment of prostate cancer
12/07/1999	US5998205 Vectors for tissue-specific replication
12/07/1999	US5998193 Genetic engineering
12/07/1999	US5998140 Complexes of cell with oligomer
12/07/1999	US5998137 To assess predisposition or susceptibility to a number of diseases: osteoporosis, atherosclerosis, cancer and immune disorders.
12/07/1999	US5997872 Isolated nucleic acid molecule coding for tumor rejection antigen precursor MAGE-C1 and uses thereof
12/07/1999	US5997871 Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin
12/07/1999	US5997870 Isolated peptides which bind to HLA-B44 Molecules
12/07/1999	US5997869 Peptides containing a fusion joint of a chimeric protein encoded by DNA spanning a tumor-associated chromosomal translocation and their use as immunogens
12/07/1999	US5997868 Inhibition of scatter factor for blocking angiogenesis
12/07/1999	US5997867 Method of using humanized antibody against CD18
12/07/1999	US5997866 Panel of antibodies for detecting cadherins, catenins and plaque proteins in tissues and method of using the panel
12/07/1999	US5997859 Gene encoding a conditionally lethal gene product which activates a purine- or pyrimidine-based prodrug into an agent that is cytotoxic to said metastatic carcinoma; and administering said prodrug to said patient
12/07/1999	US5997843 Radiometal complexes that localise in hypoxic tissue
12/07/1999	CA2157410C Enhanced circulation effector composition and method
12/07/1999	CA2020663C Substitution analogues of magainin peptides
12/07/1999	CA2004991C Deletion analogues of magainin peptides
12/02/1999	WO1999062315A2 Method for altering the activity of proteins of the pka signaling pathway
12/02/1999	WO1999061916A1 Identification of broadly reactive dr restricted epitopes
12/02/1999	WO1999061617A1 Interleukins-21 and 22
12/02/1999	WO1999061614A2 Human socs proteins
12/02/1999	WO1999061612A1 Tumor suppressor
12/02/1999	WO1999061610A2 TUMOUR SUPPRESSOR GENES OF THE p53 FAMILY
12/02/1999	WO1999061609A1 Calmodulin related protein
12/02/1999	WO1999061608A2 Polypeptides from creb binding protein and related protein p300 for use in transcriptional regulation
12/02/1999	WO1999061600A2 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3
12/02/1999	WO1999061590A1 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase src
12/02/1999	WO1999061476A1 Peptide antiangiogenic drugs
12/02/1999	WO1999061471A2 Human transmembrane proteins
12/02/1999	WO1999061469A2 Prostate growth-associated membrane proteins
12/02/1999	WO1999061467A2 Inhibition of the binding of protein tyrosine phosphatase pest to domains of signalling proteins
12/02/1999	WO1999061466A1 Antiangiogenic drug to treat cancer, arthritis and retinopathy
12/02/1999	WO1999061459A1 Alg-2lp, alg-2 like molecules and uses therefor
12/02/1999	WO1999061451A1 Platinum complex, its preparation and therapeutic application
12/02/1999	WO1999061450A1 Platinum complex, its preparation and therapeutic application
12/02/1999	WO1999061444A2 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
12/02/1999	WO1999061428A1 Quinazolines for treating brain tumor
12/02/1999	WO1999061423A1 New heterocyclically substituted amides, their production and their use
12/02/1999	WO1999061422A1 Pyrrole substituted 2-indolinone protein kinase inhibitors
12/02/1999	WO1999061421A1 A NOVEL VLA-4 INHIBITOR: oMePUPA-V
12/02/1999	WO1999061418A2 1α-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF
12/02/1999	WO1999061409A1 Bioreductive cytotoxic agents
12/02/1999	WO1999061406A2 Antiangiogenic drug to treat cancer, arthritis and retinopathy
12/02/1999	WO1999061399A1 Genes encoding epsilon lycopene cyclase and method for producing bicyclic epsilon carotene
12/02/1999	WO1999061398A2 24-hydroxyvitamin d, analogs and uses thereof
12/02/1999	WO1999061097A2 Alpha emitting constructs and uses thereof
12/02/1999	WO1999061085A2 Method and compositions for treatment of cancers
12/02/1999	WO1999061069A1 Materials and methods for delivery and expression of heterologous dna in vertebrate cells
12/02/1999	WO1999061068A1 Anti-prostate cancer vaccines, and methods of making, using and evaluating the same

1 ... 1936 1937 1938 1939 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 ... 2211